Fig. 2From: Randomized, double-blind, placebo-controlled, crossover trial of oral doxycycline for epistaxis in hereditary hemorrhagic telangiectasiaWeekly epistaxis duration by treatment allocation. Shaded boxes represent periods of doxycycline treatmentBack to article page